You searched for "blindness"

597 results found

Glaucoma screening in primary care and community settings

Glaucoma is one of the most common causes of irreversible blindness in the United States due to its insidious progression and diagnosis in late stages. The cost-effectiveness of screening for glaucoma has been debated, and screening of high-risk groups for...

The global burden of age-related macular degeneration

Age-related macular degeneration (AMD) is the third leading cause of blindness (behind cataract and refractive error). The authors present the results of the Global Burden of Disease (GBD) 2015 study, which included 195 countries. The disability-adjusted life years (DALY) due...

Glaucoma-NET: a novel way of improving glaucoma management in sub-Saharan Africa

Background Glaucoma is the second most common cause of blindness worldwide [1]. People with untreated glaucoma suffer from irreversible, progressive loss of sight. The disease is characterised by progressive loss of visual field, with pathological cupping of the optic disc...

What’s trending? Dec/Jan 2018

#scleratattoo Yes, you read that correctly. Scleral tattoos are a relatively new form of extreme body modification. Oddly enough, ‘sclera tattoo’ comes up with more hits on Twitter and YouTube than ‘scleral tattoo’. The procedure involves injecting a mixture of...

The pyramid

The first time I attended the Congress of the Royal College of Ophthalmologists was now more than 10 years ago, though I still remember the excitement of wandering down the aisles in the exhibition hall marvelling at the stands and...

Eye research: where next?

Eye research in the UK is underfunded relative to other areas of medical research and general awareness of sight loss and its prevention remains poor, messages that were reinforced in presentations and discussions during a recent research summit meeting in...

Situation analysis of diabetic retinopathy services in eleven countries

A five-year project funded by The Queen Elizabeth Diamond Jubilee Trust is facilitating development of diabetic retinopathy services (DRS) to reduce unnecessary blindness in 10 Commonwealth countries through the establishment of a capacity-building network, the DR-NET part of the Commonwealth...

2019 ICO-Allergan Research Fellowship awarded

Dr Matias Iglicki, from the University of Buenos Aires in Argentina, has been selected as the second recipient of the International Council of Ophthalmology (ICO)-Allergan Fellowship Award, by a panel of leading experts.

Urban Changes and Rural Struggles for Ophthalmology in China

China is by far the most populated country in the world, with over 1.3 billion inhabitants. It is also the country with the highest number of blind and visually impaired people. As a developing country, half of China’s population lives...

Michael Burdon to begin term of office as a BCPB Trustee

Michael Burdon begins his term of office as a BCPB Trustee in July 2020, and in October 2020 will become Chairman of the Council when Paul Hunter retires after six years.

Transfected RPE cells inhibit AMD in rats

Age-related macular degeneration (AMD) is a leading cause of blindness in the elderly. Wet AMD is characterised by choroidal neovascularisation, new vessels into the retina, leading to leakage and tissue damage. Many proangiogenic factors particularly vascular endothelial growth factor (VEGF)...

Outcomes of ‘treat and extend’ for neovascular AMD

The authors report on 24-month outcomes of anti-vascular endothelial growth factor (anti-VEGF) therapy using a ‘treat and extend’ regime for treatment-naïve neovascular age-related macular degeneration (nAMD). Data for this study was collected from the Fight Retinal Blindness observational registry based...